Cardiac cells grow in response to a number of stimuli that activate intracellular signaling pathways. The cAMP-signaling pathway mediates the activation of gene transcription in other cell types by the cAMP response element binding protein (CREB-P). Our aim was to explore the physiological role of CREB-P in response to elevated cAMP in cardiac cells by determining if phosphorylation of CREB-P (to phosphoCREB-P) rapidly induces transcription in culture. Primary embryonic chick heart cultures were used in which cAMP was raised by forskolin (5 ,mol/L) or isoproterenol (10 ,umol/L) treatment. Since both these agents have inotropic effects, tension production was controlled with 2,3-butanedione monoxime (BDM). This allowed us to determine whether the cAMP-signaling pathway or the contractile state was regulating phosphorylation and transcription. The responses for time periods up to 2 hours were assayed with antibodies to C ardiac cells grow in response to hormonal and mechanical stimuli that activate intracellular signaling pathways. An increase in myocyte size can be induced in primary cultures by adrenergic receptor activation, which also produces inotropic changes in cardiac muscle activity.1 Much of the work in heart has focused on the a1-adrenergic-coupled pathway, which has been shown to increase protein synthesis in cultured and isolated myocytes.2-5However, the relative contribution of the different intracellular signaling pathways is still not fully understood and can differ depending on specific conditions, such as cell density.6
The cAMP Response Element Binding Protein Is Expressed and Phosphorylated in Cardiac Myocytes Paul H. Goldspink, Brenda Russell Abstract Cardiac cells grow in response to a number of stimuli that activate intracellular signaling pathways. The cAMP-signaling pathway mediates the activation of gene transcription in other cell types by the cAMP response element binding protein (CREB-P). Our aim was to explore the physiological role of CREB-P in response to elevated cAMP in cardiac cells by determining if phosphorylation of CREB-P (to phosphoCREB-P) rapidly induces transcription in culture. Primary embryonic chick heart cultures were used in which cAMP was raised by forskolin (5 ,mol/L) or isoproterenol (10 ,umol/L) treatment. Since both these agents have inotropic effects, tension production was controlled with 2,3-butanedione monoxime (BDM). This allowed us to determine whether the cAMP-signaling pathway or the contractile state was regulating phosphorylation and transcription. The responses for time periods up to 2 hours were assayed with antibodies to C ardiac cells grow in response to hormonal and mechanical stimuli that activate intracellular signaling pathways. An increase in myocyte size can be induced in primary cultures by adrenergic receptor activation, which also produces inotropic changes in cardiac muscle activity.1 Much of the work in heart has focused on the a1-adrenergic-coupled pathway, which has been shown to increase protein synthesis in cultured and isolated myocytes.2-5However, the relative contribution of the different intracellular signaling pathways is still not fully understood and can differ depending on specific conditions, such as cell density. 6 A second signaling pathway that can induce cardiac hypertrophy is the ,B-adrenergic system,78 but it appears to have less influence than the a,-adrenergic pathway. 3, 9 Several studies have implicated cAMP and cAMPdependent protein kinase (PKA) as possible intracellular signals involved in the regulation of growth. For instance, increased aortic pressure accelerates protein synthesis via a cAMP-dependent mechanism, and exposure of the heart to cAMP-elevating hormones or drugs can increase the rate of protein synthesis.10l1l Hyperthyroidism is another condition that both induces hypertrophy and elevates the levels of cAMP. 12 In other cell types, the activation of gene transcription by the cAMPsignaling pathway is mediated by the cAMP response element binding protein (CREB-P). Our aim was to detect phosphoCREB-P and by quantitative filter hybridization for creb gene expression. The staining intensity of the phosphoprotein increased in myocyte nuclei after 10 minutes and persisted for 1 hour with either forskolin or isoproterenol treatment. An increase in creb mRNA abundance was also detected, with the maximum level of expression being at 1 hour with forskolin treatment. These changes are independent of the contractile state, because BDM itself caused no change. BDM plus forskolin induced the same pattern of creb expression as observed with forskolin alone. Therefore, we conclude that elevation of cAMP leads to phosphorylation of CREB-P and an increase in creb mRNA abundance. (Circ Res. 1994;74: 1042-1049.) Key Words * cAMP response element binding proteinsignal transduction * protein kinase A * 2,3-butanedione monoxime explore the physiological role of CREB-P in response to elevated cAMP by determining if phosphorylation of CREB-P rapidly induces transcription in cardiac muscle. However, since /3-adrenergic agonists exert strong inotropic and chronotropic effects on contractile activity, they are accompanied by an increase in beating. Beating itself causes the rate of protein synthesis to rise above that of contractile arrested cells.13 The drug 2,3-butanedione monoxime (BDM) is a negative inotropic agent that blocks contraction by uncoupling the electrical and mechanical events of the muscle.14 Thus, it can be used to determine whether the cAMP-signaling pathway or the contractile state of the muscle is involved in the regulation of f8-adrenergic-induced growth.
In tissues that are responsive to hormones, cAMP is known to regulate transcription of certain genes (Reference 15 and references therein). For example, a region of the somatostatin gene promoter, named the cAMP response element (CRE), binds CREB-P. The catalytic subunit of PKA can phosphorylate CREB-P and induce an increase in transcription. [16] [17] [18] Thus, the following question arises: Can CREB-P convey cytoplasmic signals that are generated on 18-adrenergic stimulation to the nucleus in cardiac muscle? Accordingly, the present study was designed to examine whether CREB-P is present in cardiac tissue and to determine whether phosphorylation of CREB-P takes place in response to elevated cAMP. Also, we sought to determine whether creb gene expression is regulated by the cAMP intracellular signaling pathway or by the contractile state of the muscle and, finally, whether the creb gene acts as an early response gene in the cascade of gene expression. To address these questions, a muscle cell culture system was used in which the signals of interest were regulated via pharmacologic intervention of the cAMP pathway.
Materials and Methods Primary Cardiac Muscle Cell Culture
Fertilized chicken eggs were incubated at 38°C for 10 days. Hearts from 10-day (stage-36) embryos were dissected and minced in Dulbecco's Ca2`and Mg 2-free phosphate-buffered saline (PBS, pH 7.4). Dissociation of the cells took place in an enzyme solution (0.25% trypsin, 0.01% pancreatin, and 0.1% bovine serum albumin [BSA] in Ca2+and Mg 2-free PBS at pH 7.6) at 37°C for 45 minutes with gentle agitation every 15 minutes. Heat-denatured horse serum was added to the incubation mixture, and the cells were pelleted by centrifugation (1000 rpm at 4°C). The cells were resuspended in cold culture media by pipetting the solution several times to disrupt any aggregates. After three washes, the cells were suspended in 5 mL of media, and an aliquot was removed for counting by the Trypan blue exclusion method. The cells are plated at a density of 1000 cells per square millimeter, which yields cultures in which there is cell contact and -6x 106 cells per 90-mm plate. The culture media used was a 1:1 mixture of Dulbecco's modified Eagle's medium and nutrient mixture F-12 (Ham's), both without L-glutamine. The complete media contained the standard amino acid concentrations plus palmitic (2.56 mg/L) and linoleic (0.84 mg/L) fatty acids and the antibiotics penicillin (50 U/mL) and gentamicin (50 mg/L). To enrich the myocyte population, preplating the cells for a period of 30 minutes allowed nonmuscle cells to adhere preferentially to the dish and thus generate a myocyte-rich supernatant. Also, omission of L-glutamine from the media selectively controls the fibroblast population and bears no ill effects on myocyte growth.19 The media were replaced every 24 hours, and the cells were maintained for 4 days before any treatment was applied. All chemicals and culture materials were purchased from Sigma.
Treatment of the myocyte cultures was carried out by the addition of pharmacologic agents to the extracellular media. To increase cAMP, forskolin and L-isoproterenol HCl (both from Sigma) were used. A 10 -mmol/L stock of each was made; forskolin dissolved in dimethyl sulfoxide was used at a final concentration of 5 ,mol/L. Isoproterenol was dissolved in 1 mmol/L HCl and used at a final concentration of 10 ,umol/L in the presence of 100 umol/L ascorbic acid. To block contraction BDM was used at a final concentration of 5 mmol/L. Control cultures in which the media were replaced with untreated media were run alongside the experimental cultures for each time point. During the experiment, the viability of the cells was monitored by the characteristics that myocytes generally show in culture: refractile cytoplasm and spontaneous beating. The beat frequency of the myocytes was monitored as an index of the contractile state achieved with the various treatments. Five random fields were selected in which the number of contractions over 20 seconds was counted and used to calculate the beats per minute. Forskolin treatment did not increase the number of beats per minute but noticeably increased the strength of contraction. BDM alone blocked beating altogether, whereas a combination of BDM and forskolin caused no significant decrease in the beats per minute but caused a noticeable reduction in the strength of contraction compared with the control condition.
Immunocytochemistry
Cells were grown on 12-mm round glass coverslips in 24-well tissue culture dishes. At the end of each time period, the cells were washed twice in Dulbecco's Ca2`and Mg 2`-free PBS.
Fixation was carried out by submersion in 4% paraformaldehyde (20 minutes at room temperature), followed by a wash in 70% ethanol (5 minutes). The coverslips were then stored in fresh 70% ethanol at 4°C until use. For antibody labeling, the coverslips were immersed in PBS with 3% BSA for at least 45 minutes. Duration of incubation in the primary antibody was for 1 hour at room temperature or overnight at 4°C, depending on the antibody being used. Removal of any excess was accomplished with three 5-minute washes in PBS. Incubation in the secondary antibody was for 1 hour, followed by washing and mounting onto glass slides.
The primary antibodies used were from a variety of different sources. The CREB-P polyclonal antibodies were a kind gift from Dr M. Greenberg, Harvard University. The CREB-P antibody was raised against a bacterial TrpE-CREB-P fusion protein and recognizes CREB-P in any state of phosphorylation. This antibody was used at a dilution of 1: 500. The phosphoCREB-P antibody was raised against the phosphorylated form of CREB-P and purified on an affinity chromatography column containing the unphosphorylated CREB-P peptide. This antibody is specific for phosphoCREB-P and was used at a final working dilution of 1:1000.20 The myosin antibody CCM52 is specific for the myosin heavy chain isoforms of the chick myocardium and was used at a dilution of 1:5000. Secondary antibodies were either goat anti-rabbit or anti-mouse IgGs labeled with fluorescein or Texas red (Sigma). The cells were viewed with a Nikon Microphot FXA microscope, and random fields were photographed with Kodak TMAX film. Coded slides were used for analysis and photography to avoid previous knowledge of the experimental state of the cells.
Western Blotting
Whole-cell protein extracts were prepared from 90-mm dishes containing 6x 106 cells. Cells were washed twice in PBS for 5 minutes, and then the cell membranes were dissolved with lysis buffer (50 mmol/L Tris at pH 7.0, 1% sodium dodecyl sulfate [SDS], and 2% 2-mercaptoethanol) at 100°C and scraped into an Eppendorf tube with a rubber policeman. The extract was boiled for 5 minutes and cooled on ice. Approximately 100 gg of cell extract was loaded onto 10% SDSpolyacrylamide gel and separated. Lanes of the gel were removed and stained with Coomassie blue to determine correct separation; the remainder were electrotransferred to nitrocellulose. The efficiency of transfer was determined by use of prestained molecular weight markers and by staining part of the nitrocellulose with Ponceau S solution. After transfer, the blot was rinsed twice in Tris-buffered saline with Tween 20 (TBST, containing 10 mmol/L Tris at pH 7.4, 150 mmol/L NaCl, and 0.05% Tween 20) . Blocking was carried out with 4% BSA in TBST for 60 minutes at 22°C in a sealed plastic bag. The blocking solution was replaced with the primary antibody for overnight incubation with shaking. Removal of excess antibody was performed with three 5-minute washes in 0.5% BSA in TBST before incubation in the secondary antibody solution. The secondary antibody was goat anti-rabbit alkaline phosphatase-conjugated IgG (Sigma). Incubation in this solution, which contains 5% BSA in TBST and the antibody at 1:5000, was for 1 hour. The blot was then subjected to three more 5-minute washes in 0.5% BSA in TBST, followed by the alkaline phosphatase detection reaction using nitro blue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate as substrates.
Probes
A 650-nt fragment (cut from creb/trpE path 11 plasmid with Sal IIPst I) was from the N-terminal of a polymerase chain reaction-amplified creb gene and was used to detect creb expression. This was a kind gift from Dr M. Greenberg, Harvard University. A 1-kb fragment (Kpn I/Pst I subcloned into Bluescribe M13+) of the chicken skeletal a-actin gene was used to probe expression of that gene.21 Total RNA was probed with the EcoRI fragment (5.7 kb) from rat 18S RNA.22
Probes were labeled by the random-primer extension method with (a-32P)dCTP. The total radioactivity of incorporated label was determined after trichloroacetic acid precipitation by scintillation counting.
RNA Extraction and Hybridization
Cells were washed twice in cold Ca'and Mg 2+-free PBS and then extracted in the dish by the single-step extraction method. 23 The concentration and purity of the RNA was determined by the ratio of absorbance at 260 to 280. Denatured RNA was loaded onto nitrocellulose filters with the aid of a slot-blotting apparatus and according to published protocols.24 Filters were washed in 6 x standard saline citrate (SSC) before prehybridization at 44°C for at least 2 hours (prehybridization solution: 6 x SSC, 0.5% SDS, 5 x Denhardt's solution, and 200 ,ug/mL denatured salmon sperm DNA). Hybridization with cDNA probes was achieved at 44°C for 18 hours by replacing the solution with one that contained 1xlO6cpm/mL of a-32P-labeled probe. Unbound probe was removed by a series of low-stringency washes (2x SSC and 0.5% SDS for 15 minutes at room temperature [RT], 2x SSC and 0.1 % SDS for 15 minutes at RT, and 0.1x SSC and 0.5% SDS for 1 hour at 65°C). For quantification, the counts per minute were taken directly from the filter using a beta scan (Betagen). Quantification of the specific signal was determined by the ratio of the slopes (counts per minute per microgram of RNA) between the control and experimental conditions at different time points and concentrations. To achieve this, three concentrations of RNA were loaded for each experimental time point and the control on duplicate filters. Sets of filters were hybridized simultaneously under the same conditions with the experimental probes and then rehybridized later with the 18S probe. The RNA loaded for each concentration (in counts per minute per microgram) was used to determine the slope for each experimental time point and control. Comparison of the slopes within the filter gave the response to the drug with respect to RNA from the control untreated cells. Comparison between hybridizations normalized the response of the gene, ie, creb, to the total RNA (18S).
Statistics
Data are given as mean±SEM. Statistical probability was assessed by ANOVA, followed by a multiple comparison procedure using the Bonferroni t test. A value of P<.05 was taken to indicate a statistically significant difference between groups compared.25
Results
Immunolocalization of CREB-P Double staining with the CREB-P antibody and the myosin antibody shows that the nuclei of both muscle and nonmuscle cells stain positive for CREB-P (Fig 1) . Under these culture conditions, the nonmuscle cells make up a relatively small population of the total number of cells (-10%). The CREB-P antibody immunoreacts with the phosphorylated and dephosphorylated form of the protein to give an intense nuclear stain and a punctate cytoplasmic stain (Fig la and lc) . However, the staining within the cytoplasm can be reduced by preabsorption of the CREB-P antibody with TrpE protein (4°C overnight). After this, the cytoplasmic staining resembles the staining associated with the secondary antibody alone while the nuclear staining remains (Fig le and lf) . The crossreactivity appears to be due to a TrpE-like epitope in the cytoplasm and TrpE antibodies in the antisera. Therefore, we conclude that the nuclear staining observed with Elevating cAMP and CREB-P Phosphorylation The pattern of immunostaining with the phos-phoCREB-P antibody after treatment with forskolin or isoproterenol for 10 minutes shows a variable intensity (Fig 2) . Cells were also double-labeled with the myosin antibody to ensure that the phosphorylation pattern observed was that of the muscle cells. In the control cultures, no nuclear staining pattern was observed in the myocytes but was present in nonmuscle cells (Fig 2a  and 2b) . On treatment with either forskolin or isoproterenol, the myocytes display an increase in the nuclear staining intensity (Fig 2c through 2f) . The onset of the myocyte nuclei staining was detectable after 10 minutes and remained for up to 1 hour with either treatment (Fig 3) . The nuclear staining in nonmuscle cells that was present in control cultures did not change with either forskolin or isoproterenol treatment.
Western blot analysis using the phosphoCREB-P antibody detects a protein that migrates as a doublet with a molecular mass of :43 kD identified as CREB-P ( Fig 4A) . Low levels of phosphoCREB-P were detected in the control lanes (lanes 1 and 4) , which probably correspond to the phosphoCREB-P levels observed in nonmuscle cells. After 1 hour of either forskolin (lanes 2 and 5) or isoproterenol (lanes 3 and 6) treatment, the amount of phosphoCREB-P can be seen to increase above the control value. To ensure that uneven loading was not responsible for these changes, identical lanes were stained with an antibody against fl-tubulin, which is not expected to change over this time period ( Fig 4B) . The level of tubulin in both lanes is equal, indicating that the protein was loaded evenly and that the results observed were in response to the treatments.
Creb Gene Expression With Elevated cAMP
The time course of creb mRNA accumulation was followed in response to forskolin treatment. As shown in Fig 5, an increase in the creb gene expression above control levels with forskolin treatment was detected after 30 minutes. Within each filter, the lane with the maximum expression was set to 100%, and the rest of the lanes were calculated with respect to that lane. A significant increase in the level of expression was detected at 1 hour with a 1.8-fold increase above control levels (control mean, 38.8+4.3% [n=31]; 1-hour mean, 69.5 ±4.5% [n=30]). Prolonged treatment with forskolin resulted in a decline in expression toward the control level of expression.
To determine whether cAMP stimulation works directly on contractile muscle gene expression, we looked at the mRNA of the skeletal a-actin gene. The time course of expression with forskolin treatment showed no significant increase in the level of expression for up to 2 hours of forskolin treatment (data not shown).
Creb Gene Expression With BDM and Forskolin Treatments
The time course of creb expression in the presence of 5 mmol/L BDM alone showed no significant increase above the level of control for periods up to 12 hours (data not shown). Thus, a combination of forskolin and BDM could be used to determine whether creb expression was responsive to the contractile state or was the the antisera represents CREB-P.
result of stimulating the cAMP pathway. The time With prolonged treatment, the level of expression declined toward the control level.
Discussion
Our results demonstrate that CREB-P is present in the nuclei of chicken cardiac muscle. We examined the transcriptional role of CREB-P in response to activation of the PKA pathway and found that CREB-P is phosphorylated on the elevation of cAMP. Also, expression of the creb gene increased and may be part of the early transcriptional events that take place on the elevation of cAMP.
How PKA actually targets CREB-P and regulates transcription is not fully understood (reviewed in Ref- erence 26) . In other tissues. CREB-P phosphorylation occurs via translocation of the catalytic subunit of PKA to the nucleus.18 Nuclear phosphorylation of CREB-P by PKA occurs at a single site (serine 133), which then activates transcription.27 In heart cells, phosphorylation of CREB-P occurred under 10 minutes. The activation of transcription could be taking place through several mechanisms. It is known that transcription can take place from CREB-P dimers bound to high-affinity and low-affinity CREs.28 Genes with high-affinity CREs (TGACGTCA) may be the first to become transcriptionally active because of the activation of bound dimers by phosphorylation. In the heart cells, the phosphory- lation persisted for 1 hour, which may thus allow for transcription over longer time periods. Over this longer time period, transcription of genes with low-affinity CREs (CGTCA) may occur by phosphorylation-dependent binding of CREB-P dimers to activate transcription.
An increase in de novo synthesis of new CREB-P monomers and the rate of dimer formation from the monomeric pool may also be part of the response to elevated cAMP. The amount of phosphoCREB-P appears to be greater after 1 hour of forskolin treatment than after isoproterenol treatment, as shown in the Western blot. This difference may be due to the fact that forskolin has an intracellular site of action, whereas isoproterenol works at the receptor on the extracellular surface. Also, desensitization of the /3-adrenergic receptors to isoproterenol after 1 hour may be taking place, which may cause a reduction in the response to the drug. Nevertheless, the higher amounts of phosphoCREB-P after 1 hour of treatment may be a result of increased synthesis. Thus, the increase in the creb mRNA abundance at 1 hour that occurred in response to forskolin treatment may represent a positive-feedback loop. In fact, promoter analysis of the human creb gene has shown the existence of three nonpalindromic CREs, which are capable of binding CREB-P and inducing transcriptional trans-activation when transfected into cells.29 Thus, phosphorylated CREB-P may increase the synthesis of new CREB-P, which is then further phosphorylated to activate other genes.
We found CREB-P and phosphoCREB-P in the nuclei of nonmuscle cells in control cultures. In culture, these nonmuscle cells are capable of proliferation unlike terminally differentiated myocytes. Therefore CREB-P may be involved in the regulation of proliferation of nonmuscle cells. In fact, if transgenics are made with a mutated creb gene encoding a nonphosphorylatable form of CREB-P, atrophy of the pituitary gland occurs. This is due to hypoplasia of the somatotroph cells that express the mutant CREB-P.301 The existence of more than one isoform of CREB-P may explain the doublet that stained with the phos-phoCREB-P antibody in the Western blot. Isoforms of CREB-P can arise via alternate splicing in other cell types. The two most abundant isoforms are CREB-P 341 and CREB-P 327, which differ from each other by 14 amino acids. The missing 14 amino acids from CREB-P 327 correspond to the trans-activating region that interacts with the phosphorylation motif to stimulate transcription. The precise role of CREB-P 327 is not known, but it is thought that it might compete with CREB-P 341 to downregulate the response to cAMP. 31 Two important questions yet to be answered are as follows: Which genes are regulated directly by CREB-P? Does CREB-P regulate the expression of muscle genes in response to elevated cAMP? We show that one function of phosphoCREB-P may be to autoregulate the creb gene itself within a short time. In this way, the initial response of the existing CREB-P on phosphorylation may be to increase the synthesis of more CREB-P and other transcription factors.
Another interesting feature is that the increase in creb gene expression follows a time course very similar to that reported for the induction of proto-oncogenes. As in a number of models of myocyte hypertrophy, one of the earliest genetic events is the induction of the proto-oncogene program, followed much later by the increased expression of muscle genes.232-38 Depending on whether the appearance of new transcripts or the abundance of specific mRNAs is measured, the onset of muscle gene expression varies in response to elevated cAMP. New a-myosin heavy chain transcripts can be detected after 12 hours of elevated cAMP,39 whereas the maximum abundance of the skeletal a-actin gene mRNA occurs after 24 hours of f8-adrenergic pathway stimulation.2,40 However, using filter hybridization, we saw no change in the abundance of the skeletal a-actin mRNA within 2 hours of forskolin treatment. Therefore, CREB-P is not acting directly on muscle genes on the elevation of cAMP but may do so at a later time point by triggering a cascade of transcriptional events.
Elevating cAMP leads to a number of physiological changes due to the phosphorylation of regulatory pro-teins associated with the Ca2`dynamics and the contractile properties of the heart. In particular, beating appears to regulate protein synthesis and even the expression of contractile protein isoforms. For example, the /-myosin isoform is downregulated if the beating is blocked and returns to normal levels if the blockage is removed. 41 In other studies, the reduction of contraction has generally taken place via blocking the electrical activities and Ca' entry into the heart. However, these methods still allow crossbridge attachment and the maintenance of tension within the myofibrils.
The maintenance of tension within the myofibrils that are linked to the cell membrane may act as a mechanical transducer in a fashion similar to myocyte stretching. Conditions under which stretching of the myocytes occurs are associated with the activation of a number of potential intracellular signaling pathways that may regulate gene expression.42 For these reasons, BDM was used to block contraction at the level of the actin-myosin interaction. It does this by altering the Ca' sensitivity of the myofibrils and Ca' availability from the sarcoplasmic reticulum but leaves the electrical membrane events intact.43 This allowed us to determine whether crossbridge formation and the generation of tension would alter the response of CREB-P to cAMP. Direct action of the drug was ruled out, since there was no change in the phosphorylation of CREB-P or the expression of the creb gene when contraction was blocked with BDM alone. However, when a combination of BDM and forskolin was used, creb gene expression increased in a manner identical to that observed with forskolin alone. Thus, we conclude that the cAMP intracellular signaling pathway induced the phosphorylation and gene expression independent of the contractile state of the muscle cells.
The activation of multiple signaling pathways occurs physiologically under conditions of mechanical stretching and those associated with stress of the myocardium, such as hypoxia.44 Also, stimulation of the ,B-adrenergic receptor-coupled pathway leads to a number of events that occur before elevation of cAMP, which increase intracellular calcium because of an increased influx and release from intracellular stores. It has been shown that this may also act as a signaling pathway linked to 3-adrenergic regulation of myocardial gene expression.45 This cross talk between signaling pathways or activation of associated pathways may also phosphorylate CREB-P and induce transcription in muscle. In other cell types, CREB-P can be phosphorylated by other kinases, such as protein kinase C and Ca2'-dependent calmodulin protein kinase, in response to a number of differing stimuli.20,46,47 However, the significance of activating these alternative signaling pathways on CREB-P phosphorylation and expression in muscle has yet to be determined.
In summary, we interpret our results to support a physiological role of CREB-P on stimulation of the cAMP signal transduction pathway in cardiac muscle. The data show that CREB-P can be phosphorylated rapidly and that this can be sustained in the presence of elevated cAMP. Also, an increase in creb gene expression is the result of stimulating the cAMP intracellular signaling pathway and is not due to the contractile activity of the cardiac myocytes. his critical review of this manuscript and Dr M.E. Greenberg for providing the CREB-P antibodies and plasmid for this study.
